Atopic dermatitis (AD) is a chronic inflammatory skin disease that predominantly affects children (1), but that can persist or start in adulthood (2,3). The diagnosis of adult AD is sometimes difficult; indeed, it can present with atypical clinical phenotypes (4). Dupilumab, is a recent valid therapeutic option for adult AD patients (5,6). As AD is a chronic disease, it is important for clinicians following patient's response to treatments.
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis
Patruno, C;
2020-01-01
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease that predominantly affects children (1), but that can persist or start in adulthood (2,3). The diagnosis of adult AD is sometimes difficult; indeed, it can present with atypical clinical phenotypes (4). Dupilumab, is a recent valid therapeutic option for adult AD patients (5,6). As AD is a chronic disease, it is important for clinicians following patient's response to treatments.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
